Scholar Rock wins FDA approval for first drug to target SMA muscle loss
Scholar Rock wins FDA approval for first drug to target SMA muscle loss STAT
2026
FDA Approves Apitegromab for Spinal Muscular Atrophy
FDA Approves Apitegromab for Spinal Muscular Atrophy NeurologyLive